Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Century Therapeutics (IPSC) Intangibles (2024 - 2025)

Century Therapeutics (IPSC) has disclosed Intangibles for 2 consecutive years, with $34.2 million as the latest value for Q3 2025.

  • On a quarterly basis, Intangibles rose 1.18% to $34.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was $34.2 million, a 1.18% increase, with the full-year FY2024 number at $34.2 million, changed N/A from a year prior.
  • Intangibles was $34.2 million for Q3 2025 at Century Therapeutics, roughly flat from $34.2 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $34.2 million in Q4 2024 to a low of $33.3 million in Q2 2024.